Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease-Reference-Cited by-同舟云学术

Eicosapentaenoic acid to arachidonic acid (EPA/AA) ratio as an associated factor of high risk plaque on coronary computed tomography in patients without coronary artery disease

Published:2016-07 Issue: Volume:250 Page:30-37
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Nagahara Yasuomi,Motoyama Sadako,Sarai Masayoshi,Ito Hajime,Kawai Hideki,Takakuwa Yoko,Miyagi Meiko,Shibata Daisuke,Takahashi Hiroshi,Naruse Hiroyuki,Ishii Junichi,Ozaki Yukio

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference40 articles.

1. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins;Baigent;Lancet,2005

2. Intensive versus moderate lipid lowering with statins after acute coronary syndromes;Cannon;N. Engl. J. Med.,2004

3. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N. Engl. J. Med.,2005

4. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials;Baigent;Lancet,2010

5. Marine n-3 polyunsaturated fatty acids in adipose tissue and therisk of acute coronary syndrome;Joensen;Circulation,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized Trial for Evaluation in Secondary Prevention Efficacy of Combination Therapy–Statin and Eicosapentaenoic Acid (RESPECT-EPA);Circulation;2024-08-06

2. Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes;American Journal of Kidney Diseases;2024-08

3. Circulating metabolites and coronary heart disease: a bidirectional Mendelian randomization;Frontiers in Cardiovascular Medicine;2024-05-21

4. OMEGA-3 POLYUNSATURATED FATTY ACIDS ADMINISTRATION IN PREVENTION OF POSTOPERATIVE ATRIAL FIBRILLATION DURING CORONARY ARTERY BYPASS GRAFT SURGERY;Complex Issues of Cardiovascular Diseases;2024-03-29

5. Simultaneous evaluation of fatty acid and triglycerides after percutaneous coronary intervention;Journal of Cardiology;2022-08